Literature DB >> 25477247

Hepatitis C virus-induced reduction in miR-181a impairs CD4(+) T-cell responses through overexpression of DUSP6.

Guang Y Li1, Yun Zhou, Ruo S Ying, Lei Shi, Yong Q Cheng, Jun P Ren, Jeddidiah W D Griffin, Zhan S Jia, Chuan F Li, Jonathan P Moorman, Zhi Q Yao.   

Abstract

UNLABELLED: T cells play a crucial role in viral clearance or persistence; however, the precise mechanisms that control their responses during viral infection remain incompletely understood. MicroRNA (miR) has been implicated as a key regulator controlling diverse biological processes through posttranscriptional repression. Here, we demonstrate that hepatitis C virus (HCV)-mediated decline of miR-181a expression impairs CD4(+) T-cell responses through overexpression of dual specific phosphatase 6 (DUSP6). Specifically, a significant decline of miR-181a expression along with overexpression of DUSP6 was observed in CD4(+) T cells from chronically HCV-infected individuals compared to healthy subjects, and the levels of miR-181a loss were found to be negatively associated with the levels of DUSP6 overexpression in these cells. Importantly, reconstitution of miR-181a or blockade of DUSP6 expression in CD4(+) T cells led to improved T-cell responses including enhanced CD25 and CD69 expression, increased interleukin-2 expression, and improved proliferation of CD4(+) T cells derived from chronically HCV-infected individuals.
CONCLUSION: Since a decline of miR-181a concomitant with DUSP6 overexpression is the signature marker for age-associated T-cell senescence, these findings provide novel mechanistic insights into HCV-mediated premature T-cell aging through miR-181a-regulated DUSP6 signaling and reveal new targets for therapeutic rejuvenation of impaired T-cell responses during chronic viral infection.
© 2014 by the American Association for the Study of Liver Diseases.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 25477247      PMCID: PMC4376593          DOI: 10.1002/hep.27634

Source DB:  PubMed          Journal:  Hepatology        ISSN: 0270-9139            Impact factor:   17.425


  40 in total

Review 1.  Novel therapeutic approaches for hepatitis C.

Authors:  J S Au; P J Pockros
Journal:  Clin Pharmacol Ther       Date:  2013-10-14       Impact factor: 6.875

2.  KLRG1 impairs CD4+ T cell responses via p16ink4a and p27kip1 pathways: role in hepatitis B vaccine failure in individuals with hepatitis C virus infection.

Authors:  Lei Shi; Jia M Wang; Jun P Ren; Yong Q Cheng; Ruo S Ying; Xiao Y Wu; Shu M Lin; Jeddidiah W D Griffin; Guang Y Li; Jonathan P Moorman; Zhi Q Yao
Journal:  J Immunol       Date:  2013-12-13       Impact factor: 5.422

3.  Reduction of microRNA 122 expression in IFNL3 CT/TT carriers and during progression of fibrosis in patients with chronic hepatitis C.

Authors:  Emilie Estrabaud; Martine Lapalus; Philippe Broët; Kevin Appourchaux; Simon De Muynck; Olivier Lada; Michelle Martinot-Peignoux; Ivan Bièche; Dominique Valla; Pierre Bedossa; Patrick Marcellin; Michel Vidaud; Tarik Asselah
Journal:  J Virol       Date:  2014-03-26       Impact factor: 5.103

4.  Transcriptional suppression of miR-181c by hepatitis C virus enhances homeobox A1 expression.

Authors:  Anupam Mukherjee; Shubham Shrivastava; Joydip Bhanja Chowdhury; Ranjit Ray; Ratna B Ray
Journal:  J Virol       Date:  2014-04-30       Impact factor: 5.103

Review 5.  Immune responses to HCV and other hepatitis viruses.

Authors:  Su-Hyung Park; Barbara Rehermann
Journal:  Immunity       Date:  2014-01-16       Impact factor: 31.745

6.  Tim-3 alters the balance of IL-12/IL-23 and drives TH17 cells: role in hepatitis B vaccine failure during hepatitis C infection.

Authors:  Jia M Wang; Cheng J Ma; Guang Y Li; Xiao Y Wu; Penny Thayer; Pamela Greer; Ashley M Smith; Kevin P High; Jonathan P Moorman; Zhi Q Yao
Journal:  Vaccine       Date:  2013-03-14       Impact factor: 3.641

Review 7.  Immune exhaustion and immune senescence: two distinct pathways for HBV vaccine failure during HCV and/or HIV infection.

Authors:  Zhi Q Yao; Jonathan P Moorman
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2013-02-12       Impact factor: 4.291

Review 8.  The role of microRNAs in hepatitis C virus replication and related liver diseases.

Authors:  Chang Ho Lee; Ji Hyun Kim; Seong-Wook Lee
Journal:  J Microbiol       Date:  2014-05-29       Impact factor: 3.422

Review 9.  Emerging concepts in immunity to hepatitis C virus infection.

Authors:  Hugo R Rosen
Journal:  J Clin Invest       Date:  2013-10-01       Impact factor: 14.808

10.  Enhanced virus-specific CD8+ T cell responses by Listeria monocytogenes-infected dendritic cells in the context of Tim-3 blockade.

Authors:  Cheng J Ma; Jun P Ren; Guang Y Li; Xiao Y Wu; Dirk G Brockstedt; Peter Lauer; Jonathan P Moorman; Zhi Q Yao
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  20 in total

1.  DUSP6 Inhibitor (E/Z)-BCI Hydrochloride Attenuates Lipopolysaccharide-Induced Inflammatory Responses in Murine Macrophage Cells via Activating the Nrf2 Signaling Axis and Inhibiting the NF-κB Pathway.

Authors:  Fan Zhang; Bufu Tang; Zijiao Zhang; Di Xu; Guowu Ma
Journal:  Inflammation       Date:  2019-04       Impact factor: 4.092

2.  Protection of CD4+ T cells from hepatitis C virus infection-associated senescence via ΔNp63-miR-181a-Sirt1 pathway.

Authors:  Yun Zhou; Guang Y Li; Jun P Ren; Ling Wang; Juan Zhao; Shun B Ning; Ying Zhang; Jian Q Lian; Chang X Huang; Zhan S Jia; Jonathan P Moorman; Zhi Q Yao
Journal:  J Leukoc Biol       Date:  2016-06-27       Impact factor: 4.962

Review 3.  Regulation of cardiac hypertrophy and remodeling through the dual-specificity MAPK phosphatases (DUSPs).

Authors:  Ruijie Liu; Jeffery D Molkentin
Journal:  J Mol Cell Cardiol       Date:  2016-08-27       Impact factor: 5.000

4.  Protein phosphatase 1 abrogates IRF7-mediated type I IFN response in antiviral immunity.

Authors:  Ling Wang; Juan Zhao; Junping Ren; Kenton H Hall; Jonathan P Moorman; Zhi Q Yao; Shunbin Ning
Journal:  Eur J Immunol       Date:  2016-08-29       Impact factor: 5.532

5.  Hepatitis C virus-induced myeloid-derived suppressor cells regulate T-cell differentiation and function via the signal transducer and activator of transcription 3 pathway.

Authors:  Jun P Ren; Juan Zhao; Jun Dai; Jeddidiah W D Griffin; Ling Wang; Xiao Y Wu; Zheng D Morrison; Guang Y Li; Mohamed El Gazzar; Shun B Ning; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-06-22       Impact factor: 7.397

6.  DUSP6 mediates T cell receptor-engaged glycolysis and restrains TFH cell differentiation.

Authors:  Wei-Chan Hsu; Ming-Yu Chen; Shu-Ching Hsu; Li-Rung Huang; Cheng-Yuan Kao; Wen-Hui Cheng; Chien-Hsiung Pan; Ming-Sian Wu; Guann-Yi Yu; Ming-Shiu Hung; Chuen-Miin Leu; Tse-Hua Tan; Yu-Wen Su
Journal:  Proc Natl Acad Sci U S A       Date:  2018-08-07       Impact factor: 11.205

7.  Transcriptomic Analysis of Chronic Hepatitis B and C and Liver Cancer Reveals MicroRNA-Mediated Control of Cholesterol Synthesis Programs.

Authors:  Sara R Selitsky; Timothy A Dinh; Cynthia L Toth; C Lisa Kurtz; Masao Honda; Benjamin R Struck; Shuichi Kaneko; Kasey C Vickers; Stanley M Lemon; Praveen Sethupathy
Journal:  mBio       Date:  2015-12-08       Impact factor: 7.867

8.  pERK-dependent defective TCR-mediated activation of CD4+ T cells in end-stage renal disease patients.

Authors:  Ling Huang; Nicolle H R Litjens; Nynke M Kannegieter; Mariska Klepper; Carla C Baan; Michiel G H Betjes
Journal:  Immun Ageing       Date:  2017-06-19       Impact factor: 6.400

9.  Decline of miR-124 in myeloid cells promotes regulatory T-cell development in hepatitis C virus infection.

Authors:  Jun P Ren; Lin Wang; Juan Zhao; Ling Wang; Shun B Ning; Mohamed El Gazzar; Jonathan P Moorman; Zhi Q Yao
Journal:  Immunology       Date:  2016-11-11       Impact factor: 7.397

Review 10.  miR-181a-regulated pathways in T-cell differentiation and aging.

Authors:  Chulwoo Kim; Zhongde Ye; Cornelia M Weyand; Jörg J Goronzy
Journal:  Immun Ageing       Date:  2021-06-15       Impact factor: 6.400

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.